News
16h
MedPage Today on MSNInvestigational Long-Acting Drug Safe in Phenotypic MASHEfimosfermin is a long-acting engineered variant of FGF21 designed to have a prolonged half-life, the authors noted, and has ...
Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...
Studies during the past decade have shown dramatically that the duration and intensity of action of many drugs in animals depend ... endoplasmic reticulum of the liver cell. These enzymes catalyze ...
Experiments conducted in cells and lab animals have shown that the liver, which plays a role in vaccine responses and infections, displays a large number of such circadian-dependent genes. 3 However, ...
Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral ...
Next, Shulman and his team want to use their method to test the effects of these and other metabolism-related drugs on liver ...
First, cinnamon oil and cinnamic acid can activate receptors such as PXR and AhR, which regulate the production of liver enzymes responsible for drug metabolism, Church says. The activation of ...
FRIDAY, June 6, 2025 (HealthDay News) — A repurposed diabetes drug can be an effective tool against fatty liver disease, a ...
While studying the liver's role in metabolism, researchers from the University ... While these are absolutely game-changing weight-loss drugs, there's nonetheless a point at which things slow ...
Next, Shulman and his team want to use their method to test the effects of these and other metabolism-related drugs on liver metabolism. They also want to follow study volunteers with MASLD and MASH ...
Dapagliflozin is a sodium glucose cotransporter 2 (SGLT2) inhibitor, a type of diabetes drug that lowers blood sugar by increasing the amount of glucose that’s secreted in urine. Fatty liver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results